Search clinical trials for: Tigecycline (Tygacil)

Total 60 results

Pfizer

Completed

Tygacil Drug Use Investigation (TIGER)

Intra-Abdominal Infections | Skin Disease, Infectious
Pfizer

Completed

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Infection
Pfizer

Completed

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Complicated Skin and Skin Structure Infections | Complicated Intra-abdominal Infections

Philippines
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

Liver Cirrhosis, Biliary

United States, Puerto Rico
Pfizer

Completed

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Complicated Skin and Skin Structure Infections | Complicated Intra-abdominal Infections | Community-Acquired Bacterial Pneumonia

Korea, Republic of
Pfizer

Completed

Post-Authorization Study Evaluating Safety Of Tigecycline (HORUS)

Intra-Abdominal Infections | Skin Disease, Infectious | Soft Tissues Infections
Zhujiang Hospital

Unknown

Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)

Critically Ill | Bacterial Infection

China
Mahidol University

Unknown

Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii

Antibiotic Resistant Infection

Thailand
Manjunath Prakash Pai
Pfizer

Completed

Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects

Obesity

United States
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center; University of California, Los Angeles; University of Kansas

Completed

Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Canada
The University of Texas Health Science Center at...
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Tigecycline for Treatment of Rapidly Growing Mycobacteria

Mycobacterium Abscessus Lung Disease | Rapidly Growing Mycobacterial Lung Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Bacterial Infections | Skin Diseases, Infectious | Skin Diseases, Bacterial | Pneumonia, Bacterial | Intra-Abdominal Infection

Taiwan, United States, South Africa, Belgium, Mexico, Ukraine
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Peritonitis

Germany
Gary E. Stein, Pharm.D.
Pfizer

Completed

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Diarrhea | Clostridium Difficile

United States
Pfizer

Completed

Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Skin Diseases | Infection
Phramongkutklao College of Medicine and Hospital
Silpakorn University

Recruiting

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

Carbapenem Resistant Klebsiella Pneumoniae

Thailand
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

Gram-Negative Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Abdominal Abscess

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

Community-Acquired Infections

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

Abdominal Abscess

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia

Cross Infection | Community Acquired Pneumonia | Bacterial Pneumonia
Zealand University Hospital

Recruiting

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

Microbial Disease

Denmark
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

Staphylococcal Skin Infections | Bacterial Skin Diseases | Skin Structure Infections

United States, Puerto Rico
Pfizer

Terminated

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Pneumonia, Bacterial

Canada, United States, Argentina, Australia, Brazil, Chile, Colombia, Croatia, France, Hungary, Korea, Republic of, Latvia, Russian Federation, Taiwan
King Faisal University

Suspended

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Infections, Bacterial

Saudi Arabia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Cholecystitis | Appendicitis | Diverticulitis | Intra-Abdominal Abscess | Intra-Abdominal Infection | Peritonitis

Italy, Spain, China, France, Switzerland, Australia, Denmark, Finland, Germany, Greece, Hong Kong, India, Philippines, Portugal, Saudi Arabia, South Africa, Taiwan, Turkey, United Kingdom
Pfizer

Withdrawn

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Community Acquired Bacterial Pneumonia | Complicated Intra-Abdominal Infection
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Community Acquired Bacterial Pneumonia | Complicated Intra-Abdominal Infection
Clinica Universidad de Navarra, Universidad de...
University of Navarrra Hospital (Clinica Universitaria)

Unknown

Concentration of Antimicrobials in Catheter-lock Solutions (CONAN)

Catheter-Related Infections | Bacteremia.

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection

Cross Infection | Cholecystitis | Appendicitis | Diverticulitis | Peritonitis

United States, Canada, Chile, Argentina, Brazil, Mexico
Achaogen, Inc.
Department of Health and Human Services

Completed

A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) (CARE)

Bloodstream Infections (BSI) Due to CRE | Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE | Ventilator-Associated Bacterial Pneumonia (VABP) Due to CRE | Complicated Urinary Tract Infection (cUTI) Due to CRE | Acute Pyelonephritis (AP) Due to CRE
University of California, San Diego

Completed

A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia

End-Stage Renal Disease | Hemodialysis Catheter-associated Infection

United States
Shandong University
Shandong Provincial Hospital

Recruiting

Antibiotic Therapy for Infectious Diseases

Infectious Disease

China
Ramathibodi Hospital

Completed

Clinical Efficacy of Glucosamine Plus Diacerein Versus Mono-therapy of Glucosamine

Osteoarthritis | Glucosamine | Diacerein

Thailand
CPL Associates
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection

Staphylococcal Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Gram-Positive Bacterial Infections | Cross Infection
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

Gram-Positive Bacterial Infections | Methicillin Resistance | Staphylococcus Infections | Vancomycin Resistance
University of California, San Diego

Terminated

Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections

Infection; Dialysis Catheter

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

Bacterial Infections

Poland, Germany
Federico II University

Withdrawn

Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation

Infection of Skin and/or Subcutaneous Tissue

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Skin Diseases, Infectious

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Diabetic Foot | Bacterial Infections | Osteomyelitis

China, Colombia, Estonia, Denmark, Taiwan, France, United States, Canada, Spain, Belgium, Austria, Chile, Korea, Republic of, Mexico, Slovakia, United Kingdom, Russian Federation, Croatia, Turkey, Lithuania, Poland, Latvia, Finland, H... and more
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

Bacterial Pneumonia

United States
University of California, San Diego
National Institutes of Health (NIH)

Withdrawn

Treatment of Hemodialysis Catheter-Related Bacteremia

Hemodialysis Catheter-related Bacteremia

United States
Institute of Liver and Biliary Sciences, India

Recruiting

A Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF for the Management of Spontaneous Bacterial Peritonitis Presenting With Septic Shock.

Spontaneous Bacterial Peritonitis

India
Maimónides Biomedical Research Institute of Córdoba

Completed

Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical

Acinetobacter Infections
Shandong University
The Second Hospital of Shandong University

Recruiting

Population Pharmacokinetics and Dosage Individualization of Antibiotics in Elderly Patients

Elderly Infection

China
Centocor, Inc.

Completed

A Study to Assess the Safety and Pharmacokinetics of a Single Intravenous Administration of CNTO 328 Derived From 2 Different Cell Lines in Healthy Participants

Healthy

United States

Search clinical trials for: Tigecycline (Tygacil)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations